Search Within

Marinela Capanu

Formats
  1. Journal Article (232)
  2. Meeting Abstract (158)
  3. Correspondence (3)
  4. Miscellaneous (1)
Groups
  1. Biostatistics Service (394)
  2. Center for Pancreatic Cancer Research (394)
  3. Epidemiology and Biostatistics (394)
  4. Department of Medicine (313)
  5. Solid Tumor Oncology Division (310)
  6. Gastrointestinal Oncology Service (280)

More Groups

People
  1. Joanne Chou (167)
  2. David Kelsen (98)
  3. Eileen O'Reilly (97)
  4. Ghassan Abou-Alfa (67)
  5. David Ilson (65)
  6. Yelena Janjigian (61)

More People

Years
  1. 2025 (17)
  2. 2024 (23)
  3. 2023 (21)
  4. 2022 (24)
  5. 2021 (24)
  6. 2020 (25)

More Years

Publications
  1. Journal of Clinical Oncology (147)
  2. Cancer (18)
  3. Annals of Oncology (15)
  4. Abdominal Radiology (14)
  5. Clinical Cancer Research (12)
  6. Annals of Surgical Oncology (11)

More Publications

Publishers
  1. American Society of Clinical Oncology (152)
  2. Springer (42)
  3. Wiley Blackwell (31)
  4. Oxford University Press (29)
  5. Elsevier Inc. (21)
  6. Lippincott Williams & Wilkins (21)

More Publishers

Results (394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • False discovery rates for rare variants from sequenced data
    Journal Article

    Capanu, M.; Seshan, V. E.
    Genetic Epidemiology (2015)

    Fulltext@MSK | Save
  • Activity of genacitabine/5-FU combination in refractory esophagogastrie (EG) cancer
    Meeting Abstract

    Won, E.; Ilson, D. H.; Chou, J. F.; Capanu, M.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Pretreatment neutrophil to lymphocyte ratio as an independent predictor of disease-specific survival in resectable GE junction and gastric adenocarcinoma
    Meeting Abstract

    Wang, S. C.; Chou, J. F.; Strong, V. E.; Brennan, M. F.; Capanu, M.; Coit, D. G.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase IB trial of cisplatin (C), gemcitabine (G), and veliparib (V) in patients with known or potential BRCA or PALB2-mutated pancreas adenocarcinoma (PC)
    Meeting Abstract

    O'Reilly, E. M.; Lowery, M. A.; Segal, M. F.; Smith, S. C.; Moore, M. J.; Kindler, H. L.; Golan, T.; Segal, A.; Salo-Mullen, E. E.; Hollywood, E.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Treatment, outcomes, and clinical trial participation in very elderly patients (pts) with metastatic pancreas cancer (mPC)
    Meeting Abstract

    Li, D.; Capanu, M.; Yu, K. H.; Lowery, M. A.; Kelsen, D. P.; O'Reilly, E. M.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Medical oncology patient readmissions: Are they preventable?
    Meeting Abstract

    Epstein, A. S.; Crosbie, C.; Martin, S.; Egan, B.; Goring, T.; Koo, D.; Kumar, C.; Salvit, C.; Capanu, M.; Saltz, L.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Response rates to hepatic arterial infusion (HAI) pump therapy in patients with metastatic colorectal cancer liver metastases (mCRC LM) after progression on all standard chemotherapies
    Meeting Abstract

    Cercek, A.; Aguilo, A.; Gluskin, J.; Chou, J. F.; Reidy, D. L.; Saltz, L.; Siegel, C.; Capanu, M.; Jarnagin, W. R.; DeMatteo, R. P.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • 30-day-or-sooner readmissions of gastrointestinal medical oncology patients following cancer center inpatient service discharge: Characteristics and preventability
    Journal Article

    Epstein, A. S.; Crosbie, C.; Martin, S. C.; Egan, B.; Goring, T. N.; Koo, D. J.; Kumar, C. B.; Salvit, C.; Capanu, M.; Chou, J.; more...
    Hospital Practice (2014)

    Fulltext@MSK | Save
  • Ganetespib, a novel Hsp90 inhibitor in patients with KRAS mutated and wild type, refractory metastatic colorectal cancer
    Journal Article

    Cercek, A.; Shia, J.; Gollub, M.; Chou, J. F.; Capanu, M.; Raasch, P.; Reidy-Lagunes, D.; Proia, D. A.; Vakiani, E.; Solit, D. B.; more...
    Clinical Colorectal Cancer (2014)

    Fulltext@MSK | Save
  • KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases
    Journal Article

    Kemeny, N. E.; Chou, J. F.; Capanu, M.; Gewirtz, A. N.; Cercek, A.; Kingham, T. P.; Jarnagin, W. R.; Fong, Y.; DeMatteo, R. P.; Allen, P. J.; more...
    Cancer (2014)

    Fulltext@MSK | Save